Chemed CorporationCHENYSE

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Latest News

247wallst.com

Here Are Thursday’s Top Wall Street Analyst Research Calls: Alphabet, Callaway Golf, Datadog, Hyatt Hotels, Palantir, Texas Instruments, Verizon, and More

Pre-Market Stock Futures: The futures are trading higher this morning, following a solid bounce-back rally across the major indices on Wednesday, after the worst day for stocks since October. Stocks were headed lower at the open, but as President Trump addressed the audience at the World Economic Forum in Davos, Switzerland, the moment he mentioned... Here Are Thursday's Top Wall Street Analyst Research Calls: Alphabet, Callaway Golf, Datadog, Hyatt Hotels, Palantir, Texas Instruments, Verizon, and More.

globenewswire.com

Chemed to Report Fourth-Quarter 2025 Earnings February 25, Related Conference Call to Be Held on February 26

CINCINNATI, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2025, on Wednesday, February 25, 2026, following the close of trading on the New York Stock Exchange.

defenseworld.net

Chemed Corporation $CHE Stock Holdings Decreased by Harbor Capital Advisors Inc.

Harbor Capital Advisors Inc. decreased its stake in shares of Chemed Corporation (NYSE: CHE) by 65.3% during the undefined quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,166 shares of the company's stock after selling 2,197 shares during the period. Harbor Capital Advisors Inc.'s holdings in

defenseworld.net

Chemed Corporation (NYSE:CHE) Receives $574.25 Average Target Price from Brokerages

Shares of Chemed Corporation (NYSE: CHE - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the six ratings firms that are covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1-year price

zacks.com

Should Investors Hold Chemed Stock in Their Portfolio Now?

CHE shows growth momentum from VITAS and resilient Roto-Rooter results, but macro headwinds and competition continue to cloud its near-term outlook.

zacks.com

Chemed (CHE) Upgraded to Buy: Here's What You Should Know

Chemed (CHE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

defenseworld.net

Fisher Asset Management LLC Has $4.75 Million Stake in Chemed Corporation $CHE

Fisher Asset Management LLC lowered its position in Chemed Corporation (NYSE: CHE) by 15.0% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 9,762 shares of the company's stock after selling 1,721 shares during the quarter. Fisher Asset Management

globenewswire.com

Chemed Corporation to Present at the BofA Securities 2025 Virtual Home Care Conference

CINCINNATI, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will present at the BofA Securities 2025 Virtual Home Care Conference on Tuesday, December 9, 2025, at 1:20 PM (ET). The presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations).

defenseworld.net

Edgestream Partners L.P. Acquires 6,233 Shares of Chemed Corporation $CHE

Edgestream Partners L.P. increased its stake in shares of Chemed Corporation (NYSE: CHE) by 435.3% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,665 shares of the company's stock after buying an additional 6,233 shares during the

defenseworld.net

Creative Planning Decreases Position in Chemed Corporation $CHE

Creative Planning lowered its stake in shares of Chemed Corporation (NYSE: CHE) by 4.3% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,675 shares of the company's stock after selling 120 shares during the quarter. Creative Planning's holdings in Chemed were worth

defenseworld.net

Boston Partners Boosts Holdings in Chemed Corporation $CHE

Boston Partners raised its stake in shares of Chemed Corporation (NYSE: CHE) by 37.1% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 22,651 shares of the company's stock after purchasing an additional 6,125 shares during the quarter. Boston

seekingalpha.com

Chemtrade Logistics Income Fund (CHE.UN:CA) Q3 2025 Earnings Call Transcript

Chemtrade Logistics Income Fund ( CHE.UN:CA ) Q3 2025 Earnings Call November 12, 2025 10:00 AM EST Company Participants Rohit Bhardwaj - VP of Finance & CFO Scott Rook - CEO, President & Trustee Conference Call Participants Nikolai Goroupitch Joel Jackson - BMO Capital Markets Equity Research Ben Isaacson - Scotiabank Global Banking and Markets, Research Division Presentation Operator Good morning, ladies and gentlemen, and welcome to Chemtrade Logistics Income Fund Third Quarter 2025 Conference Call. [Operator Instructions] I would now like to turn the conference call over to Rohit Bhardwaj, Chief Financial Officer.

seekingalpha.com

Chemed Corporation (CHE) Presents at UBS Global Healthcare Conference 2025 Transcript

Chemed Corporation ( CHE ) UBS Global Healthcare Conference 2025 November 11, 2025 2:00 PM EST Company Participants Michael Witzeman - Executive VP, Controller, Principal Accounting Officer & CFO Kevin McNamara - CEO, President & Director Joel Wherley - CEO, President & Chief Operating Officer Conference Call Participants Albert Rice - UBS Investment Bank, Research Division Presentation Albert Rice UBS Investment Bank, Research Division All right. Thanks, everyone.

zacks.com

Wall Street Analysts Predict a 32.69% Upside in Chemed (CHE): Here's What You Should Know

The mean of analysts' price targets for Chemed (CHE) points to a 32.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

globenewswire.com

Chemed Corporation Declares Quarterly Dividend of 60 Cents

CINCINNATI, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 60-cents per share on the Company's capital stock, payable on December 5, 2025, to shareholders of record as of November 17, 2025. This is equal to the dividend paid in August 2025. This represents the 218th consecutive quarterly dividend paid by Chemed in its 54 years as a public company.

globenewswire.com

Chemed Corporation to Present at the UBS 2025 Global Healthcare Conference

CINCINNATI, Ohio, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will deliver a presentation at the UBS 2025 Global Healthcare Conference on Tuesday, November 11, 2025, at approximately 2:00 p.m. (ET) at the PGA National Resort in Palm Beach Gardens, Florida.

fool.com

Schwartz Offloads 28,000 Chemed (CHE) Shares Valued at $13 Million

Schwartz Investment Counsel sold 28,771 shares of Chemed Corporation; estimated transaction value of approximately $13.03 million based on average third-quarter 2025 pricing Trade represented 0.4% of Schwartz's reportable U.S. equity assets under management as of Q3 2025 Post-trade stake: 111,033 shares valued at $49.71 million as of Q3 2025 Chemed now accounts for 1.67% of AUM as of September 30, 2025, which places it outside the fund's top five holdings

seekingalpha.com

Chemed Corporation (CHE) Q3 2025 Earnings Call Transcript

Chemed Corporation ( CHE ) Q3 2025 Earnings Call October 29, 2025 10:00 AM EDT Company Participants Holley Schmidt Kevin McNamara - CEO, President & Director Michael Witzeman - Executive VP, Controller, Principal Accounting Officer & CFO Joel Wherley - CEO, President & Chief Operating Officer Conference Call Participants Benjamin Hendrix - RBC Capital Markets, Research Division Brian Tanquilut - Jefferies LLC, Research Division Joanna Gajuk - BofA Securities, Research Division Presentation Operator Good morning, and thank you for standing by. Welcome to the Chemed Corporation Third Quarter 2025 Earnings Conference Call.

zacks.com

CHE Stock Falls on Q3 Earnings and Revenue Miss, Margins Crash

Chemed's Q3 miss sends shares lower as shrinking margins and weaker EPS overshadow steady revenue gains from VITAS and Roto-Rooter.

zacks.com

Chemed (CHE) Lags Q3 Earnings and Revenue Estimates

Chemed (CHE) came out with quarterly earnings of $5.27 per share, missing the Zacks Consensus Estimate of $5.39 per share. This compares to earnings of $5.64 per share a year ago.

Loading news...

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance